Aziyo biologics provides business update and reports first quarter 2022 financial results

Silver spring, md., may 09, 2022 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today provided a business update and reported financial results for the first quarter march 31, 2022.
AZYO Ratings Summary
AZYO Quant Ranking